🔗 Share this article

Texas Attorney General Paxton is taking legal action against the producers of Tylenol, asserting the companies concealed safety concerns that the pain reliever created to children's neurological development.

This legal action arrives thirty days after President Donald Trump advocated an unproven link between using acetaminophen - alternatively called acetaminophen - while pregnant and autism spectrum disorder in offspring.

The attorney general is taking legal action against J&J, which formerly manufactured the medication, the exclusive pain medication recommended for expectant mothers, and Kenvue, which presently makes it.

In a statement, he said they "misled consumers by profiting off of suffering and pushing pills without regard for the potential hazards."

The manufacturer says there is lacking scientific proof linking acetaminophen to autism spectrum disorder.

"These companies deceived for years, intentionally threatening numerous people to boost earnings," the attorney general, a Republican, stated.

The company said in a statement that it was "deeply concerned by the spread of false claims on the security of paracetamol and the possible consequences that could have on the health of women and children in America."

On its online platform, the company also stated it had "continuously evaluated the relevant science and there is no credible data that indicates a established connection between consuming acetaminophen and autism spectrum disorder."

Groups representing physicians and health professionals concur.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the key substance in Tylenol - is among limited choices for women during pregnancy to address pain and elevated temperature, which can present significant medical dangers if ignored.

"In multiple decades of studies on the consumption of paracetamol in gestation, not a single reputable study has conclusively proven that the consumption of acetaminophen in any trimester of pregnancy leads to neurodevelopmental disorders in offspring," the organization commented.

This legal action references current declarations from the Trump administration in claiming the drug is reportedly hazardous.

Last month, Trump generated worry from public health officials when he instructed women during pregnancy to "struggle intensely" not to take Tylenol when sick.

The FDA then released a statement that physicians should contemplate reducing the consumption of Tylenol, while also mentioning that "a causal relationship" between the drug and autism in children has not been proven.

The Health Department head RFK Jr, who supervises the Food and Drug Administration, had pledged in April to initiate "comprehensive study program" that would determine the source of autism spectrum disorder in a short period.

But specialists advised that discovering a single cause of autism spectrum disorder - believed by scientists to be the consequence of a complex mix of inherited and surrounding conditions - would be difficult.

Autism spectrum disorder is a form of enduring cognitive variation and disability that influences how individuals perceive and interact with the surroundings, and is diagnosed using physician assessments.

In his legal document, Paxton - aligned with the former president who is campaigning for federal office - claims Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the evidence" around acetaminophen and autism.

This legal action seeks to make the companies "destroy any promotional materials" that states Tylenol is reliable for women during pregnancy.

The Texas lawsuit parallels the grievances of a group of guardians of children with autism spectrum disorder and ADHD who sued the makers of Tylenol in recently.

A federal judge rejected the lawsuit, declaring studies from the plaintiffs' authorities was inconclusive.